Hypertension Treatment in Nigeria 2.0

Starting soon · Not applicable

Conditions studied: Hypertension (HTN)

In brief

The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory, Nigeria. This program demonstrated significant improvements in hypertension treatment and control. HTN 2.0 will expand implementation of the HEARTS bundle to 5 new states in 5 geopolitical zones in Nigeria (Abia, Delta, Gombe, Jigawa, and Oyo) while also evaluating sustainment of hypertension control in the Federal Capital Territory.

Key facts

Study ID

NCT07351162

Run by

Washington University School of Medicine

People needed

10000

Starts

2026-02-01

Expected to finish

2030-01-31

Last updated by the study team

2026-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (≥18 years old),
• Elevated blood pressure (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg) documented or measured by a health care professional (e.g., physician, community health extension worker, or community health officer) on two separate occasions or taking a BP-lowering medication, or a history of hypertension.
• Pregnant women are eligible for this program, or
• Cognitively impaired adults are eligible for this program..

You may not qualify if…

• This program will not include any of the following special populations:
• Individuals who are not yet adults (minors): i.e. infants, children, or teenagers <18 years old, or
• Prisoners or other detained individuals.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.